Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:address |
Mumbai, Maharashtra, India
|
| gptkbp:CEO |
Rodrigo Puga
|
| gptkbp:country |
gptkb:India
|
| gptkbp:formerName |
Aventis Pharma
|
| gptkbp:foundedYear |
1956
|
| gptkbp:headquartersLocation |
gptkb:Mumbai
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sanofi India
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:ISIN |
INE058A01010
|
| gptkbp:listedOn |
gptkb:Bombay_Stock_Exchange
gptkb:National_Stock_Exchange_of_India |
| gptkbp:parentCompany |
gptkb:Sanofi
|
| gptkbp:products |
vaccines
pharmaceutical drugs |
| gptkbp:stockExchange |
gptkb:NSE
BSE |
| gptkbp:stockSymbol |
SANOFI
|
| gptkbp:subsidiary |
gptkb:Sanofi
|
| gptkbp:website |
https://www.sanofiindialtd.com/
|
| gptkbp:bfsParent |
gptkb:Vijay_Mallya
|
| gptkbp:bfsLayer |
7
|